NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/23/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,238.44 mln
Float20.87 mln
Earnings Date09/02/2026
EPS
2.33
Solid
P / E
13.10
Fair value
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.29
Borderline
1-Year Forecast
45.60
Exceptional upside
Relative Strength
22
/ 100
Significantly lagging
Business Description
Phibro Animal Health Corporation, headquartered in Teaneck, New Jersey, produces and sells health products, nutritional supplements, and vaccines for farm animals and pets across markets in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company also supplies trace minerals such as zinc, copper, and manganese to help livestock maintain a balanced and healthy diet. In addition, it provides specialty ingredients used in personal care and industrial chemical products. Founded in 1946, Phibro reaches its customers through local sales teams, feed manufacturers, and distributors worldwide.
